Brief: AcelRx Pharmaceuticals Q2 Loss Per Share $0.08
16/08/2021 21:05
Aug 16 (Reuters) - AcelRx Pharmaceuticals Inc ACRX.O :
* ACELRX PHARMACEUTICALS REPORTS SECOND QUARTER 2021
FINANCIAL
RESULTS
* Q2 LOSS PER SHARE $0.08
* Q2 EARNINGS PER SHARE ESTIMATE $-0.08 -- REFINITIV IBES
DATA
Source text for Eikon: ID:nPn2FnFYJa
Further company coverage: ACRX.O
Recent news on Talphera
See all newsTalphera Inc reports results for the quarter ended June 30 - Earnings Summary
Talphera Inc expected to post a loss of 7 cents a share - Earnings Preview
Talphera Q1 net loss narrows as costs rise on higher development spending
Talphera Q4 net loss widens as operating expenses rise
Brief: Talphera Announces 50% Enrollment Milestone In Ongoing Nephro-Crrt Registrational Trial